Ekso Bionics Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Multiple Sclerosis Patients
13 juin 2022 08h00 HE
|
Ekso Bionics Holdings, Inc.
First FDA Cleared Exoskeleton for Rehabilitation Use in Patients with Multiple Sclerosis RICHMOND, Calif., June 13, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the...
Ekso Bionics Appoints Jerome Wong Interim Chief Financial Officer
26 mai 2022 07h00 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics to Present at the H.C. Wainwright Global Investment Conference
17 mai 2022 16h05 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that...
Ekso Bionics Reports First Quarter 2022 Results
28 avr. 2022 16h05 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics to Report First Quarter 2022 Financial Results on April 28
21 avr. 2022 08h03 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Reports Fourth Quarter and Year End 2021 Results
24 févr. 2022 16h05 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
17 févr. 2022 08h00 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Announces Leadership Transition
21 janv. 2022 16h01 HE
|
Ekso Bionics Holdings, Inc.
Board Member Steven Sherman to be Appointed CEO EVP Scott Davis to be Appointed President and COO CEO Jack Peurach to Leave the Company Effective January 21, 2022 RICHMOND, Calif., Jan. 21, 2022 ...
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results
10 janv. 2022 09h00 HE
|
Ekso Bionics Holdings, Inc.
Company Achieves Record Quarterly Revenue of $3.9 million to $4.1 million1 RICHMOND, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an...
Ekso Bionics to Participate at the H.C. Wainwright BioConnect Virtual Conference
04 janv. 2022 08h30 HE
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that...